The association of Helicobacter pylori with adverse pregnancy outcomes in three European birth cohorts.

IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Raquel Galan, Lucy Pembrey, Mariona Bustamante, Ruth Aguilar, Dan Mason, Marta Vidal, Marc Bañuls, Theano Roumeliotaki, Juana Mari Delgado-Saborit, Natalia Marin, Martine Vrijheid, Vicky Bempi, Gemma Moncunill, Carlota Dobaño, Manolis Kogevinas, Marianna Karachaliou
{"title":"The association of Helicobacter pylori with adverse pregnancy outcomes in three European birth cohorts.","authors":"Raquel Galan, Lucy Pembrey, Mariona Bustamante, Ruth Aguilar, Dan Mason, Marta Vidal, Marc Bañuls, Theano Roumeliotaki, Juana Mari Delgado-Saborit, Natalia Marin, Martine Vrijheid, Vicky Bempi, Gemma Moncunill, Carlota Dobaño, Manolis Kogevinas, Marianna Karachaliou","doi":"10.1186/s12884-024-06901-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori is a prevalent infection that may complicate pregnancy, but evidence remains limited, controversial and may not apply to all pregnant women.</p><p><strong>Objective: </strong>This study aims to evaluate whether Helicobacter pylori is a risk factor for adverse pregnancy outcomes and to identify vulnerable subpopulations.</p><p><strong>Study design: </strong>Multiplex serology was utilized to measure blood levels of immunoglobulin G against eight Helicobacter pylori antigens in 1372 pregnant women from three European birth cohorts: BiB (United Kingdom), Rhea (Greece) and INMA (Spain). Outcomes of interest included gestational diabetes mellitus, gestational hypertension, preeclampsia, preterm birth and small for gestational age neonates, as well as prenatal anxiety and depression. Adjusted logistic regression models were used to evaluate the association between Helicobacter pylori seropositivity (overall and by antigen) and antigen specific antibody levels with the outcomes. We examined effect modification of the associations by ethnicity.</p><p><strong>Results: </strong>Helicobacter pylori seropositivity was detected in 18.8% (258/1372) of pregnant women. Preeclampsia was the least common outcome (26/830). Helicobacter pylori seropositivity was associated with the development of two or more adverse pregnancy outcomes (gestational hypertension, gestational diabetes, preterm birth, small gestational age and preeclampsia) [OR:1.32 (95% CI: 1.06-1.65), p-value: 0.01], especially in women with high antibody levels to OMP antigen [OR: 2.12 (95% CI: 1.62-2.76), p-value: 0.001]. Women with high antibody levels to Helicobacter pylori antigens GroEL and NapA were more likely to develop preeclampsia [OR: 2.34 (95% CI: 1.10-8.82), p-value: 0.03; OR: 4.09 (95% CI: 1.4-11.93), p-value 0.01)]. Helicobacter pylori seropositivity increased the odds of developing any hypertensive disorder during pregnancy among women of western ethnicity (948/1372) [OR:3.35 (95% CI: 1.29-8.74), p-value 0.03].</p><p><strong>Conclusion: </strong>Our study suggests that Helicobacter pylori seropositivity is a risk factor for multiple adverse pregnancy outcomes and particularly in women of western origin for hypertensive disorders during pregnancy. Moreover, pathogen specific characteristics reflected in the antibody responses against OMP, GroEL and NapA seem to determine disease associations.</p>","PeriodicalId":9033,"journal":{"name":"BMC Pregnancy and Childbirth","volume":"24 1","pages":"745"},"PeriodicalIF":2.8000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558891/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pregnancy and Childbirth","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12884-024-06901-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Helicobacter pylori is a prevalent infection that may complicate pregnancy, but evidence remains limited, controversial and may not apply to all pregnant women.

Objective: This study aims to evaluate whether Helicobacter pylori is a risk factor for adverse pregnancy outcomes and to identify vulnerable subpopulations.

Study design: Multiplex serology was utilized to measure blood levels of immunoglobulin G against eight Helicobacter pylori antigens in 1372 pregnant women from three European birth cohorts: BiB (United Kingdom), Rhea (Greece) and INMA (Spain). Outcomes of interest included gestational diabetes mellitus, gestational hypertension, preeclampsia, preterm birth and small for gestational age neonates, as well as prenatal anxiety and depression. Adjusted logistic regression models were used to evaluate the association between Helicobacter pylori seropositivity (overall and by antigen) and antigen specific antibody levels with the outcomes. We examined effect modification of the associations by ethnicity.

Results: Helicobacter pylori seropositivity was detected in 18.8% (258/1372) of pregnant women. Preeclampsia was the least common outcome (26/830). Helicobacter pylori seropositivity was associated with the development of two or more adverse pregnancy outcomes (gestational hypertension, gestational diabetes, preterm birth, small gestational age and preeclampsia) [OR:1.32 (95% CI: 1.06-1.65), p-value: 0.01], especially in women with high antibody levels to OMP antigen [OR: 2.12 (95% CI: 1.62-2.76), p-value: 0.001]. Women with high antibody levels to Helicobacter pylori antigens GroEL and NapA were more likely to develop preeclampsia [OR: 2.34 (95% CI: 1.10-8.82), p-value: 0.03; OR: 4.09 (95% CI: 1.4-11.93), p-value 0.01)]. Helicobacter pylori seropositivity increased the odds of developing any hypertensive disorder during pregnancy among women of western ethnicity (948/1372) [OR:3.35 (95% CI: 1.29-8.74), p-value 0.03].

Conclusion: Our study suggests that Helicobacter pylori seropositivity is a risk factor for multiple adverse pregnancy outcomes and particularly in women of western origin for hypertensive disorders during pregnancy. Moreover, pathogen specific characteristics reflected in the antibody responses against OMP, GroEL and NapA seem to determine disease associations.

欧洲三个出生队列中幽门螺杆菌与不良妊娠结局的关系。
背景:幽门螺杆菌是一种可能导致妊娠并发症的流行性感染,但相关证据仍然有限,且存在争议,可能并不适用于所有孕妇:本研究旨在评估幽门螺旋杆菌是否是导致不良妊娠结局的风险因素,并确定易受感染的亚人群:研究设计:采用多重血清学方法测量来自三个欧洲出生队列的 1372 名孕妇血液中针对八种幽门螺旋杆菌抗原的免疫球蛋白 G 水平:BiB(英国)、Rhea(希腊)和 INMA(西班牙)。研究结果包括妊娠糖尿病、妊娠高血压、子痫前期、早产和胎龄小新生儿,以及产前焦虑和抑郁。调整后的逻辑回归模型用于评估幽门螺旋杆菌血清阳性率(总体和抗原)和抗原特异性抗体水平与结果之间的关系。我们还研究了种族对相关性的影响:18.8%的孕妇(258/1372)检测出幽门螺杆菌血清阳性。子痫前期是最不常见的结果(26/830)。幽门螺杆菌血清阳性与两种或两种以上不良妊娠结局(妊娠高血压、妊娠糖尿病、早产、小胎龄和子痫前期)的发生有关[OR:1.32(95% CI:1.06-1.65),P 值:0.01],尤其是在 OMP 抗原抗体水平较高的妇女中[OR:2.12(95% CI:1.62-2.76),P 值:0.001]。幽门螺杆菌抗原 GroEL 和 NapA 抗体水平高的妇女更容易患子痫前期[OR:2.34(95% CI:1.10-8.82),P 值:0.03;OR:4.09(95% CI:1.10-2.76),P 值:0.001]:4.09(95% CI:1.4-11.93),P 值:0.01)]。幽门螺杆菌血清阳性会增加西方族裔妇女(948/1372)在妊娠期间罹患任何高血压疾病的几率[OR:3.35(95% CI:1.29-8.74),P 值:0.03]:我们的研究表明,幽门螺旋杆菌血清阳性是导致多种不良妊娠结局的危险因素,尤其是西方裔妇女妊娠期高血压疾病。此外,针对 OMP、GroEL 和 NapA 的抗体反应所反映的病原体特异性似乎决定了疾病的关联性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Pregnancy and Childbirth
BMC Pregnancy and Childbirth OBSTETRICS & GYNECOLOGY-
CiteScore
4.90
自引率
6.50%
发文量
845
审稿时长
3-8 weeks
期刊介绍: BMC Pregnancy & Childbirth is an open access, peer-reviewed journal that considers articles on all aspects of pregnancy and childbirth. The journal welcomes submissions on the biomedical aspects of pregnancy, breastfeeding, labor, maternal health, maternity care, trends and sociological aspects of pregnancy and childbirth.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信